相关实验视频

Updated: Jul 28, 2025

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI

Functional Neuroimaging Using Ultrasonic Blood-brain Barrier Disruption and Manganese-enhanced MRI

Published on: July 12, 2012

在小脑中增强的MRI信号的细胞特异性

Harikrishna Rallapalli¹, N Sumru Bayin², Hannah Goldman³

¹Department of Radiology, NYU Langone Radiology - Center for Biomedical Imaging, New York University School of Medicine, 660 First Avenue, New York, NY 10016, United States; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.

|May 28, 2023

概括

普尔金耶细胞,而不是伯格曼细胞,在小脑的增强MRI (MEMRI) 中产生信号. 这项研究澄清了MEMRI对比的细胞来源,有助于未来的MRI研究.

科学领域:

神经成像是一种神经成像.
细胞神经科学细胞神经科学
磁共振成像技术磁共振成像技术

背景情况:

磁共振成像 (MRI) 的分辨率正在进步,需要了解细胞水平的对比机制.
增强型MRI (MEMRI) 在体内可视化大脑细胞结构,特别是在小脑.
之前的研究表明,普金尼细胞层是小脑中MEMRI强度过高的来源.

研究的目的:

为了确定负责大脑Purkinje细胞层中MEMRI信号增强的特定细胞类型.
为了区分普尔金涅细胞与伯格曼细胞对MEMRI对比的贡献.

主要方法:

在小脑模型中选择性切除普尔金尼细胞.
在小脑模型中选择性切除Bergmann glia.
在细胞特异性切除后的MEMRI信号变化的量化.

主要成果:

切除普尔金尼细胞显著降低了小脑皮层MEMRI信号增强.
切除伯格曼质细胞并没有显著改变MEMRI信号增强.
这些发现证实普尔金尼细胞是MEMRI对比度的主要来源.

结论:

普尔金尼细胞是大脑小脑普尔金尼细胞层中增强的MRI对比的主要细胞来源.
这项研究验证了一种细胞剥离策略,用于将MRI对比机制分配给特定细胞类型.
这些发现有助于我们更好地理解细胞水平上的体内神经成像.

关键词:

蜂分辨率可以通过蜂进行分辨.基因工程小鼠模型的基因工程.分子成像学分子成像学多式联运登记是多式联运登记.药物遗传性废除药物遗传性废除

更多相关视频

In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging

In vitro Labeling of Human Embryonic Stem Cells for Magnetic Resonance Imaging

Published on: August 3, 2008

In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice

In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice

Published on: July 22, 2014

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...